Fluconazole Prophylaxis against Fungal Colonization and Infection in Preterm Infants
Data up to Jan 2025
Total Citations Per Year
Abstract
References (42)
Analysis of Longitudinal Data
2001 • 7,095 citations
Manual of Clinical Microbiology, 7th ed.
2000 • 1,651 citations
A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow Transplantation
1992 • 1,179 citations
Resistance of Candida species to fluconazole
1995 • 890 citations
Late-onset sepsis in very low birth weight neonates: A report from the National Institute of Child Health and Human Development Neonatal Research Network
1996 • 881 citations
Efficacy and Safety of Fluconazole Prophylaxis for Fungal Infections after Marrow Transplantation--A Prospective, Randomized, Double-Blind Study
1995 • 820 citations
The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance
1996 • 779 citations
Candidemia in Allogeneic Blood and Marrow Transplant Recipients: Evolution of Risk Factors after the Adoption of Prophylactic Fluconazole
2000 • 506 citations
Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial
2000 • 504 citations
Fluconazole Prophylaxis of Fungal Infections in Patients with Acute Leukemia: Results of a Randomized Placebo-Controlled, Double-Blind, Multicenter Trial
1993 • 374 citations
A Randomized Trial Comparing Fluconazole with Clotrimazole Troches for the Prevention of Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection
1995 • 324 citations
P Values Maximized Over a Confidence Set for the Nuisance Parameter
1994 • 310 citations
Fluconazole for Prophylaxis Against Candidal Rectal Colonization in the Very Low Birth Weight Infant
2001 • 241 citations
Fungal Colonization in the Very Low Birth Weight Infant
1986 • 231 citations
Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States
1999 • 221 citations
Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype
1994 • 218 citations
Vertical and Horizontal Transmission of Unique Candida Species to Premature Newborns
1996 • 177 citations
Randomized Trial of Fluconazole versus Nystatin for the Prophylaxis of Candida Infection following Liver Transplantation
1996 • 162 citations
Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trials.
2000 • 144 citations
P Values Maximized Over a Confidence Set for the Nuisance Parameter
1994 • 140 citations
Pharmacokinetics of fluconazole in pediatric patients
1994 • 138 citations
In Vitro Susceptibilities of Candida Bloodstream Isolates to the New Triazole Antifungal Agents BMS-207147, Sch 56592, and Voriconazole
1998 • 131 citations
Pharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of life
1993 • 126 citations
Dexamethasone Therapy Increases Infection in Very Low Birth Weight Infants
1999 • 124 citations
Prophylactic action of oral fluconazole against fungal infection in neutropenic patients
2000 • 122 citations
Neonatal Candidiasis: The Current Challenge
1991 • 122 citations
Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia
1997 • 110 citations
Outbreak ofCandida parapsilosis fungemia in neonatal intensive care units: Clinical implications and genotyping analysis
1999 • 107 citations
Emerging Evidence of Selection of Fluconazole-Tolerant Fungi in Surgical Intensive Care Units
1997 • 84 citations
Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia
1998 • 64 citations
Modulation of interactions of Candida albicans and endothelial cells by fluconazole and amphotericin B
1992 • 52 citations
Small-Sample Confidence Intervals for p 1 - p 2 and p 1 /p 2 in 2 × 2 Contingency Tables
1980 • 50 citations
Phagocytosis and killing ability of Candida albicans by blood leucocytes of healthy term and preterm babies.
1975 • 48 citations
Fluconazole in cats: Pharmacokinetics following intravenous and oral administration and penetration into cerebrospinal fluid, aqueous humour and pulmonary epithelial lining fluid
1997 • 48 citations
The changing face of nosocomial candidemia: epidemiology, resistance, and drug therapy
1999 • 47 citations
Influence of fluconazole at subinhibitory concentrations on cell surface hydrophobicity and phagocytosis ofCandida albicans
2000 • 41 citations
Effects of Sub‐Inhibitory Concentrations of Antifungal Agents on Adherence of Candida spp. to Buccal Epithelial Cells in Vitro: Die Wirkung subinhibitorischer Antimyzetika‐Konzentrationen auf die Adharenz von Candida‐Arten an Epithelzellen der Mundschleimhaut
1989 • 28 citations
Synergy of Fluconazole with Human Monocytes or Monocyte-Derived Macrophages for Killing of Candida Species
1995 • 26 citations
Effect of amphotericin B, flnconazole and itraconazole on intracellular Candida albicans and germ tube development in macrophages
1990 • 26 citations
Fluconazole prophylaxis in patients with head and neck tumours undergoing radiation and radiochemotherapy
1998 • 25 citations
Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia
1998 • 19 citations
Effects of Antifungal Pretreatment on the Susceptibility of <i>Candida albicans</i> to Human Leukocytes
1997 • 5 citations